1. Carlson JJ et al (2009) Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals. JMCP 15(8):683–687
2. EMA Guidance – Good Pharmacovigilance Practices Module V Risk Management Systems 28 April 2014
3. EMA – Good Pharmacovigilance Practices Module VIII Post-Authorization Safety Studies 20 February 2012
4. EMA Guidance – Good Pharmacovigilance Practices Module XVI: Risk Minimization Measures – Selection of Tools and Effectiveness Indicators: 28 April 2014
5. EMA Guidance – Safety and Efficacy Follow-up of Advanced Therapy Medicinal Products – Draft Guidance 2008